Prostate-specific antigen (PSA), cancer antigen 125 (CA 125), and cancer antigen 15.3 (CA 15.3) are a few examples of the biomarkers used in everyday practice (in prostate cancer, ovarian cancer, and breast cancer, respectively) to monitor response to the treatment [18]. This evidence concerns the gene KLK3 and prostate carcinoma.